Back to People & Entities
LAMIVLABA
Organization
1
Total Mentions
1
Documents
0
Connected Entities
Organization referenced in documents
Document Mentions (1)
EFTA01457560.pdf
1 mentionEFTA01457560
.V. reslizumab for severe asthma 2018 Competitor Expected launch of subcut reslizumab for severe asthma Mid-lb Competitor Potential approval of LAMIVLABA tiotropiumkiladaterol for COPD Nov-15 Avodart US patent expiry 2H16 Broo Headline results from mortalityhnorbidity Study (SUMMIT) souse- Past?
Sponsored
Connected Entities
No connected entities